Category: Antibody Technologies
Global Antibody Technologies
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors), Route of Administration (Intravitreal Injections, Oral Administration), Indication - Global Forecast 2024-2030
... estimated at USD 8.49 billion in 2023 and expected to reach USD 9.01 billion in 2024, at a CAGR 8.85% to reach USD 15.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Global Forecast 2024-2030
... to reach USD 9.47 billion in 2024, at a CAGR 23.19% to reach USD 33.14 billion by 2030. Global Biosimilar Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
Antinuclear Antibody Testing Market by Product (Reagents & Assay Kits, Services, Software), Technique (Enzyme-linked immunosorbent assay (ELISA), Indirect immunofluorescent (IIF), Multiplex immunoassay), Technology, Indication, End-User - Global Forecast
... was estimated at USD 1.77 billion in 2023 and expected to reach USD 1.95 billion in 2024, at a CAGR 10.49% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Research Report 2024(Status and Outlook)
... The Global Adalimumab Monoclonal Antibody Biosimilar Market Size was estimated at USD 473.99 million in 2023 and is projected to reach USD 960.91 million by 2029, exhibiting a CAGR of 12.50% during the forecast period. ... Read More
-
Global Trastuzumab Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... Trastuzumab Monoclonal Antibody Market Size was estimated at USD 4768.03 million in 2023 and is projected to reach USD 6316.94 million by 2029, exhibiting a CAGR of 4.80% during the forecast period. This report provides ... Read More
-
Global Markets for Research Antibodies
... include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market ... Read More
-
Cancer Immunotherapy Market based on by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics),Regional Outlook– Global Forecast up to 2030
... 2030 Cancer immunotherapy medications are intended to enhance or augment the body's natural immune response to combat cancer. This market is research-driven, with a significant reliance on the identification of compounds capable of eliciting an ... Read More
-
Protein Therapeutics Market (Product: Monoclonal Antibodies, Enzyme Replacement Therapy, Cytokines, Fusion Proteins, Anti-coagulants, Bone Morphogenetic Proteins (BMPs), Hormones, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Scope of Report TMR’s report on the global protein therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2028
... market is projected to reach USD 8.4 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 8.4% during the forecast period. Market growth is driven by factors such as the rising ... Read More
-
Global Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Regional Outlook and Forecast, 2023 - 2030
... 2030 The Global Antibody Therapeutics Market size is expected to reach $631.3 billion by 2030, rising at a market growth of 14.4% CAGR during the forecast period. Antibody therapeutics are explored to prevent and treat ... Read More
-
Neutralizing Antibody Market Forecasts to 2030 – Global Analysis By Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, Broadly Neutralizing Antibody, Cross Neutralizing Antibody and Other Antibody Types), Distribution Channel, Application, End User and By Geography
... to Stratistics MRC, the Global Neutralizing Antibody Market is accounted for $190.4 billion in 2023 and is expected to reach $385.4 billion by 2030 growing at a CAGR of 10.6% during the forecast period. The ... Read More
-
2024 Global Antibody Drug Conjugates Contract Manufacturing Industry (2030 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product ... Read More
-
2024 Global Forecast for Cancer Monocolonal Antibodies (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Myasthenia Gravis Disease Treatment Market Forecasts to 2030 – Global Analysis By Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Transient Neonatal Myasthenia Gravis and Other Types), Drug Class (Cholinesterase Inhibitors, Monoclonal Antibodies, Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography
... Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography According to Stratistics MRC, the Global Myasthenia Gravis Treatment Market is accounted for $2.2 billion in 2023 and is expected to reach $3.9 ... Read More
-
2024 Global Antinuclear Antibody (Ana) Test Market Industry (2030 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product ... Read More
-
Biologics Outsourcing Market Forecasts to 2030 – Global Analysis By Product (Antibodies, Vaccines, Recombinant Proteins and Other Products), Type (Instruments and Kits & Reagents), Source, Service, Application, End User and By Geography
... MRC, the Global Biologics Outsourcing Market is accounted for $23.78 billion in 2023 and is expected to reach $62.20 billion by 2030 growing at a CAGR of 16.0% during the forecast period. Biologics Outsourcing refers ... Read More
-
2024 Global Antibody-Drug Conjugates Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
2024 Global Antibody Fragments Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2024-2028
... forecast period. The report on the ctla4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. ... Read More
-
2024 Global: Antibody Fragments - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Antibody-Drug Conjugates - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Antibodies Contract Manufacturing - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
Research Assistance
